Fulvestrant Stada Arzneimittel

Fulvestrant is a medication used for hormone receptor-positive breast cancer treatment. This intramuscular injection is designed to block estrogen receptors, potentially slowing cancer growth.

Fulvestrant is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by binding to estrogen receptors, which may help to inhibit the growth of cancer cells. This medication is often considered for advanced or metastatic breast cancer that has progressed despite other treatments.

Common effects of Fulvestrant may include injection site reactions, such as pain, swelling, or redness. Some individuals might experience fatigue, nausea, or headaches. These effects vary and are not experienced by everyone.

Fulvestrant should be administered by a healthcare professional. It is important to discuss any existing medical conditions or allergies with your healthcare provider before starting this treatment. Regular monitoring may be required during therapy.

Fulvestrant may interact with other medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with your healthcare provider.